Pro Medicus Limited PMCUF OTC · Healthcare · Australia
$136.55 +0.00% +$0.00
Summary
79 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 63% a year over the last 3 years.
- Out of every 100 AUD of revenue, 101 AUD is left as net profit.
- It earns 25 AUD a year on every 100 AUD of invested capital.
- It holds more cash than debt: $146.3M against $2.23M.
What to watch
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBy our assumptions the business is worth less than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 79.8 AUD for 1 AUD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (AUD)
Diluted EPS (AUD)
- Analyst estimate
Revenue grew by 31% a year over 5 years. Over the last 3 years it grew by 28% a year. For the next fiscal year analysts expect revenue to grow by 27%. Earnings per share grew by 63% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 AUD of revenue goes
- Cost of sales 19 AUD
- Sales and administration 5.7 AUD
- Taxes and other -26 AUD
- Net profit 101 AUD
Net profit, industry median (Medical - Healthcare Information Services) 5.7 AUD
Out of every 100 AUD of revenue, 101 AUD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.39%
- Paid out of profit
- 31%
- Raised in a row
- 5 years
You receive $0.53 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Today's price within the analysts' price targets
The average target of $155 is 14% above today's price.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.